×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [fda critical path initiative]
Home >
fda critical path initiative
Ключевые аспекты ценообразования. Международная практика
505 views
Tools to Reduce Phase III Trial Failures Lawrence J. Lesko, Ph.D., FCP Director of the Office of Clinical Pharmacology and Biopharmaceutics Center for.
219 views
Critical Path: Overview of Selected Ongoing CBER Efforts and Future Opportunities Jesse L. Goodman, M.D., M.P.H Director Center for Biologics Evaluation.
215 views
FDA Critical Path Initiative: A Generic Industry Perspective
33 views